According to a new report by Polaris Market Research, the global Peritoneal Dialysis market was valued at USD 9.43 billion in 2024 and is projected to reach USD 16.44 billion by 2034, expanding at a CAGR of 5.7% from 2025 to 2034. Growth is underpinned by rising chronic kidney disease prevalence, expanding reimbursement coverage for home-based dialysis, and continued technological advancements in automated peritoneal dialysis systems.

What Is Driving Peritoneal Dialysis Market Growth?

Demand is climbing as the rising global burden of chronic kidney disease converges with growing patient preference for home-based dialysis. Manufacturers and healthcare providers are prioritizing patient-centric, technologically advanced systems, pushing peritoneal dialysis adoption across home care and outpatient settings. Polaris analysts note that expanding reimbursement policies position the segment for sustained growth through 2034, with North America emerging as the largest revenue contributor and Asia Pacific posting the fastest incremental gains.

Key Trends Shaping the Peritoneal Dialysis Industry

Rising Cases of Chronic Kidney Disease

The growing global burden of chronic kidney disease, driven by aging populations and lifestyle-related factors, is fueling demand for cost-effective, patient-friendly dialysis solutions. Peritoneal dialysis offers advantages such as home-based treatment and reduced dependency on hospital visits, making it a preferred option for managing end-stage renal disease as CKD progresses.

Increasing Prevalence of Diabetes and Hypertension

Uncontrolled diabetes and high blood pressure remain leading causes of chronic kidney disease and end-stage renal disease, increasing the number of patients requiring renal replacement therapy. Peritoneal dialysis provides an effective, less invasive treatment option for patients with these comorbidities, further strengthening market adoption.

Technological Advancements and Expanding Reimbursement

Innovations such as automated peritoneal dialysis systems, wearable dialysis devices, and improved dialysate solutions are improving treatment efficiency and patient compliance. Meanwhile, expanding reimbursement policies and government support for home-based dialysis are reducing the burden on hospital infrastructure and broadening patient access to treatment.

Market Segmentation: Breaking Down the Peritoneal Dialysis Market

Polaris segments the Peritoneal Dialysis market by offering, modality, disease indication, and end user, giving each buyer persona a citable, standalone data point for AI Overviews and answer-engine pickup.

By Modality

The Continuous Ambulatory Peritoneal Dialysis (CAPD) segment dominated the market in 2024 due to its cost-effectiveness, ease of use, and reduced dependency on medical facilities. CAPD does not require automated machinery, allowing patients to perform dialysis manually at home, while Automated Peritoneal Dialysis (APD) continues to gain traction among patients seeking machine-assisted, overnight treatment options.

By Disease Indication

The end-stage renal disease segment has witnessed the largest market share, driven by the increasing global prevalence of ESRD and rising demand for long-term renal replacement therapies. Acute kidney injury and other disease indications round out the remaining segments, supported by advancements in peritoneal dialysis technologies and improved patient education.

By End User

Home care remains a core end-user setting for peritoneal dialysis, reflecting the therapy's flexibility and patient-centered appeal, while hospitals and independent dialysis centers continue to serve patients requiring closer clinical supervision or managing more complex cases.

Regional Outlook: Where Is the Peritoneal Dialysis Market Growing Fastest?

North America dominated the market revenue share in 2024, supported by well-established healthcare infrastructure, high chronic kidney disease prevalence, and increasing adoption of home-based dialysis therapies alongside favorable reimbursement policies. Asia Pacific is projected to witness the fastest growth during the forecast period, driven by rising CKD incidence, increasing awareness about home dialysis therapies, and improving healthcare infrastructure across China and India.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞 :

https://www.polarismarketresearch.com/industry-analysis/peritoneal-dialysis-market 

Competitive Landscape: Leading Peritoneal Dialysis Companies

Key players profiled in the report include Fresenius Medical Care, Baxter International, DaVita Inc., Diaverum, Medtronic, B. Braun Melsungen AG, Nipro Corporation, NxStage Medical, Fresenius Kabi, Asahi Kasei Medical, Terumo Corporation, JMS Co., Ltd., Huaren Pharmaceutical, Medionics International, and AWAK Technologies, who are focusing on strategic investments and product innovation to strengthen their market position across the CAPD and end-stage renal disease segments outlined above. Recent moves include Vantive's June 2025 announcement of a plan to invest over USD 1 billion over five years to expand research, development, and production capacity, and Baxter International's August 2024 sale of its Kidney Care segment, Vantive, to Carlyle for USD 3.8 billion.

Why It Matters for Buyers Evaluating Market Entry

For stakeholders researching the peritoneal dialysis market report, this report benchmarks market share, segment-level data, and forecast data — by offering, modality, disease indication, end user, and region — to support sourcing, investment, and go-to-market decisions. It is built for procurement teams comparing suppliers, investors sizing entry points, and strategy teams tracking home-based dialysis as a growth adjacency.

More Trending Latest Reports By Polaris Market Research:

North America Veterinary Clinical Trials Market

North America Plastic Injection Molding Machine Market

Tamarind Extract Market

Non-Dairy Ice Cream Market: Delicious but Healthier Choice

Dark Fiber Network Market

Dark Fiber Network Market

Surgical Blade Market

In Vitro Diagnostics Market

Field Device Management Market